| Application no. and date | 13755720.3 (espacenet) (Federated) (European Patent Register), 20130301 | | Patent/reg. no. and date | DK/EP 2819682, 20170503 | | Publication date | 20150107 | | Priority no. and date | US 201261605528 P, 20120301 | | EP pub. no. and date |
EP 2819682 20150107 | | Effective date | | | Applicant/owner | Xequel Bio, Inc., 1501 Belle Isle Ave, Suite 220
Mount Pleasant, SC 29464, US | | Applicant ref. no. | P62065DK01 | | Inventor | GHATNEKAR, Gautam, 475-A East Bay Street
Charleston, SC 29403, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/74 (2006.01) , A61K 38/00 (2006.01) , A61K 38/16 (2006.01) , A61K 38/17 (2006.01) , A61K 47/38 (2006.01) , A61K 9/00 (2006.01) , A61K 9/06 (2006.01) | | Title | TOPIKALE GELER INDEHOLDENDE ALPHA-CONNEXIN C-TERMINAL (ACT) -PEPTIDER | | Int. application no. | US2013028727 | | Int. publication no. | WO2013131040 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
